<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03716310</url>
  </required_header>
  <id_info>
    <org_study_id>Sepsisplt</org_study_id>
    <nct_id>NCT03716310</nct_id>
  </id_info>
  <brief_title>Platelet Reactivity in Septic Shock</brief_title>
  <official_title>Impaired Platelet Reactivity as an Early Biomarker for Sepsis-related Thrombocytopenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi di Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi di Ferrara</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coagulation disorders and thrombocytopenia are common in patients with septic shock. Despite
      the clinical relevance of sepsis-induced thrombocytopenia, few studies have focused on the
      prediction of thrombocytopenia in this setting. The aim of this study was to evaluate whether
      platelets aggregometry and markers of platelets activation, such as mean platelet volume or
      platelet volume distribution width, could predict sepsis-induced thrombocytopenia in patients
      with septic shock and normal platelet count on the day of diagnosis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Actual">August 30, 2018</completion_date>
  <primary_completion_date type="Actual">May 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Occurence of sepsis-induced thrombocytopenia</measure>
    <time_frame>5 days after study inclusion</time_frame>
    <description>Occurence of platelet count &lt;150 *103/μL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>life-threatening bleeding</measure>
    <time_frame>After 28 days from study inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90-day mortality</measure>
    <time_frame>after 90 days from study enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of Red blood cells (RBC) packs transfused during ICU stay</measure>
    <time_frame>After 28 days from study inclusion</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Septic Shock</condition>
  <condition>Thrombocytopenia</condition>
  <condition>Sepsis</condition>
  <condition>Platelet Aggregation</condition>
  <condition>Disseminated Intravascular Coagulation</condition>
  <arm_group>
    <arm_group_label>septic shock patients</arm_group_label>
    <description>Inclusion criteria of the study were diagnosis of septic shock and a platelet count &gt;150*103/mcL.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>platelet responsiveness evaluation</intervention_name>
    <description>Blood samples were anticoagulated with 0.129 mmol/L of sodium citrate and then centrifugated for 10 min at 200 rpm; platelets aggregation was assessed with an AggRAM Advanced Modular System light transmittance aggregometer (Helena Laboratories, Beaumont, Texas, USA). Low-molecular-weight heparin (LMWH) was given at least 8 hours before any blood aggregation sample. Agonist used to initiate aggregation test were: -Adenosine diphosphate (ADP) to assess P2Y12-dependent platelet aggregation; (20 ng) - Arachidonic acid (AA) to assess cyclooxygenase-dependent platelet Adenosine diphosphate aggregation (1 mcg) - thrombin receptor-activating peptide-6 (TRAP-6) to assess protease-activated receptor 1-dependent platelet aggregation. Max aggregation reached (Aggmax), the slope of the curve (slope) and the latency time (lat) were analyzed for each agonist.</description>
    <arm_group_label>septic shock patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in intensive care unit
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of septic shock

          -  platelet count &gt;150*103/mcL.

        Exclusion Criteria:

          -  age &lt;18 years

          -  history of any hematologic disorder

          -  chronic liver failure

          -  previous chemotherapy

          -  transfusion of platelet during the previous 4 weeks

          -  renal replacement therapy before ICU admission

          -  history of antiplatelet therapy during the 8 days before inclusion

          -  history of heparin-induced thrombocytopenia (HIT) or other acquired or induced
             thrombocytopenia

          -  occurrence of HIT (defined as HIT score over 3)

          -  active bleeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Università di Ferrara</name>
      <address>
        <city>Ferrara</city>
        <zip>44121</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Campo G, Valgimigli M, Gemmati D, Percoco G, Tognazzo S, Cicchitelli G, Catozzi L, Malagutti P, Anselmi M, Vassanelli C, Scapoli G, Ferrari R. Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study. J Am Coll Cardiol. 2006 Dec 5;48(11):2178-85. Epub 2006 Nov 13.</citation>
    <PMID>17161242</PMID>
  </reference>
  <reference>
    <citation>Dewitte A, Lepreux S, Villeneuve J, Rigothier C, Combe C, Ouattara A, Ripoche J. Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critically [corrected] ill patients? Ann Intensive Care. 2017 Dec 1;7(1):115. doi: 10.1186/s13613-017-0337-7. Review. Erratum in: Ann Intensive Care. 2018 Feb 28;8(1):32.</citation>
    <PMID>29192366</PMID>
  </reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 17, 2018</study_first_submitted>
  <study_first_submitted_qc>October 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2018</study_first_posted>
  <last_update_submitted>October 19, 2018</last_update_submitted>
  <last_update_submitted_qc>October 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi di Ferrara</investigator_affiliation>
    <investigator_full_name>Alberto Fogagnolo</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Thrombocytopenia</mesh_term>
    <mesh_term>Disseminated Intravascular Coagulation</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

